This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xie, X. Articles by Sladek, F. M. Search for Related Content PubMed PubMed Citation Articles by Xie, X. Articles by Sladek, F. M.

Down-Regulation of Hepatic HNF4 Gene Expression during Hyperinsulinemia via SREBPs

Department of Physiology and Pathophysiology (X.X., H.D., W.P., Y.G., X.W., Y.Z.), Key Laboratory of Molecular Cardiovascular Sciences of Education Ministry, Peking University Health Science Center, Beijing 100083, China; and Department of Cell Biology and Neuroscience (H.L., F.M.S.) and Division of Biomedical Sciences (J.Y-J.S.), University of California, Riverside, California 92521

Address all correspondence and requests for reprints to: Frances M. Sladek, Ph.D., Department of Cell Biology and Neuroscience, University of California, Riverside, Riverside, California 92521. E-mail: frances.sladek{at}ucr.edu; or Yi Zhu, M.D., Department of Physiology and Pathophysiology, Peking University, Health Sciences Center, Beijing 100083, China. E-mail: zhuyi{at}bjmu.edu.cn.

Mutations in the coding region of hepatocyte nuclear factor 4 (HNF4), and its upstream promoter (P2) that drives expression in the pancreas, are known to lead to maturity-onset diabetes of the young 1 (MODY1). HNF4 also controls gluconeogenesis and lipid metabolism in the liver, where the proximal promoter (P1) predominates. However, very little is known about the role of hepatic HNF4 in diabetes. Here, we examine the expression of hepatic HNF4 in two diabetic mouse models, db/db mice (type 2, insulin resistant) and streptozotocin-treated mice (type 1, insulin deficient). We found that the level of HNF4 protein and mRNA was decreased in the liver of db/db mice but increased in streptozotocin-treated mice. Because insulin increases the activity of sterol regulatory element-binding proteins (SREBP)-1c and -2, we also examined the effect of SREBPs on hepatic HNF4 gene expression and found that, like insulin, ectopic expression of SREBPs decreases the level of hepatic HNF4 protein and mRNA both in vitro in primary hepatocytes and in vivo in the liver of C57BL/6 mice. Finally, we use gel shift, chromatin immunoprecipitation, small interfering RNA, and reporter gene analysis to show that SREBP2 binds the human HNF4 P1 promoter and negatively regulates its expression. These data indicate that hyperinsulinemia down-regulates HNF4 in the liver through the up-regulation of SREBPs, thereby establishing a link between these two critical transcription factor pathways that regulate lipid and glucose metabolism in the liver. These findings also provide new insights into diabetes-associated complications such as fatty liver disease.

NURSA Molecule Pages Link:

Nuclear Receptors:   HNF4α

This article has been cited by other articles:

				B. Nedumaran, S. Hong, Y.-B. Xie, Y.-H. Kim, W.-Y. Seo, M.-W. Lee, C. H. Lee, S.-H. Koo, and H.-S. Choi DAX-1 Acts as a Novel Corepressor of Orphan Nuclear Receptor HNF4{alpha} and Negatively Regulates Gluconeogenic Enzyme Gene Expression J. Biol. Chem., October 2, 2009; 284(40): 27511 - 27523. [Abstract] [Full Text] [PDF]